APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer

The accumulating evidence demonstrates that the apolipoprotein B mRNA editing enzyme catalytic polypeptide-like (APOBEC), DNA-editing protein plays an important role in the molecular pathogenesis of cancer. In particular, the APOBEC3 family was shown to induce tumor mutations by an aberrant DNA edit...

Full description

Bibliographic Details
Main Authors: Honghong Guo, Ling Zhu, Lu Huang, Zhen Sun, Hui Zhang, Baoting Nong, Yuanyan Xiong
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/12/2827
_version_ 1797489302537502720
author Honghong Guo
Ling Zhu
Lu Huang
Zhen Sun
Hui Zhang
Baoting Nong
Yuanyan Xiong
author_facet Honghong Guo
Ling Zhu
Lu Huang
Zhen Sun
Hui Zhang
Baoting Nong
Yuanyan Xiong
author_sort Honghong Guo
collection DOAJ
description The accumulating evidence demonstrates that the apolipoprotein B mRNA editing enzyme catalytic polypeptide-like (APOBEC), DNA-editing protein plays an important role in the molecular pathogenesis of cancer. In particular, the APOBEC3 family was shown to induce tumor mutations by an aberrant DNA editing mechanism. However, knowledge regarding the reconstitution of the APOBEC family genes across cancer types is still lacking. Here, we systematically analyzed the molecular alterations, immuno-oncological features, and clinical relevance of the APOBEC family in pan-cancer. We found that APOBEC genes were widely and significantly differentially expressed between normal and cancer samples in 16 cancer types, and that their expression levels are significantly correlated with the prognostic value in 17 cancer types. Moreover, two patterns of APOBEC-mediated stratification with distinct immune characteristics were identified in different cancer types, respectively. In ACC, for example, the first pattern of APOBEC-mediated stratification was closely correlated with the phenotype of immune activation, which was characterized by a high immune score, increased infiltration of CD8 T cells, and higher survival. The other pattern of APOBEC-mediated stratification was closely correlated with the low-infiltration immune phenotype, which was characterized by a low immune score, lack of effective immune infiltration, and poorer survival. Further, we found the APOBEC-mediated pattern with low-infiltration immune was also highly associated with the advanced tumor subtype and the CIMP-high tumor subtype (CpG island hypermethylation). Patients with the APOBEC-mediated pattern with immune activation were more likely to have therapeutic advantages in ICB (immunological checkpoint blockade) treatment. Overall, our results provide a valuable resource that will be useful in guiding oncologic and therapeutic analyses of the role of APOBEC family in cancer.
first_indexed 2024-03-10T00:14:34Z
format Article
id doaj.art-fd92cdfdfc684beba6a03345f00677d2
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:14:34Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-fd92cdfdfc684beba6a03345f00677d22023-11-23T15:54:51ZengMDPI AGCancers2072-66942022-06-011412282710.3390/cancers14122827APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-CancerHonghong Guo0Ling Zhu1Lu Huang2Zhen Sun3Hui Zhang4Baoting Nong5Yuanyan Xiong6Key Laboratory of Gene Engineering, Ministry of Education, Institute of Healthy Aging Research, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, ChinaKey Laboratory of Gene Engineering, Ministry of Education, Institute of Healthy Aging Research, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, ChinaKey Laboratory of Gene Engineering, Ministry of Education, Institute of Healthy Aging Research, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, ChinaKey Laboratory of Gene Engineering, Ministry of Education, Institute of Healthy Aging Research, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, ChinaKey Laboratory of Gene Engineering, Ministry of Education, Institute of Healthy Aging Research, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, ChinaKey Laboratory of Gene Engineering, Ministry of Education, Institute of Healthy Aging Research, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, ChinaKey Laboratory of Gene Engineering, Ministry of Education, Institute of Healthy Aging Research, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510006, ChinaThe accumulating evidence demonstrates that the apolipoprotein B mRNA editing enzyme catalytic polypeptide-like (APOBEC), DNA-editing protein plays an important role in the molecular pathogenesis of cancer. In particular, the APOBEC3 family was shown to induce tumor mutations by an aberrant DNA editing mechanism. However, knowledge regarding the reconstitution of the APOBEC family genes across cancer types is still lacking. Here, we systematically analyzed the molecular alterations, immuno-oncological features, and clinical relevance of the APOBEC family in pan-cancer. We found that APOBEC genes were widely and significantly differentially expressed between normal and cancer samples in 16 cancer types, and that their expression levels are significantly correlated with the prognostic value in 17 cancer types. Moreover, two patterns of APOBEC-mediated stratification with distinct immune characteristics were identified in different cancer types, respectively. In ACC, for example, the first pattern of APOBEC-mediated stratification was closely correlated with the phenotype of immune activation, which was characterized by a high immune score, increased infiltration of CD8 T cells, and higher survival. The other pattern of APOBEC-mediated stratification was closely correlated with the low-infiltration immune phenotype, which was characterized by a low immune score, lack of effective immune infiltration, and poorer survival. Further, we found the APOBEC-mediated pattern with low-infiltration immune was also highly associated with the advanced tumor subtype and the CIMP-high tumor subtype (CpG island hypermethylation). Patients with the APOBEC-mediated pattern with immune activation were more likely to have therapeutic advantages in ICB (immunological checkpoint blockade) treatment. Overall, our results provide a valuable resource that will be useful in guiding oncologic and therapeutic analyses of the role of APOBEC family in cancer.https://www.mdpi.com/2072-6694/14/12/2827APOBECpan-cancergenetic alterationstumor microenvironmentsurvivalimmunotherapy
spellingShingle Honghong Guo
Ling Zhu
Lu Huang
Zhen Sun
Hui Zhang
Baoting Nong
Yuanyan Xiong
APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer
Cancers
APOBEC
pan-cancer
genetic alterations
tumor microenvironment
survival
immunotherapy
title APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer
title_full APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer
title_fullStr APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer
title_full_unstemmed APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer
title_short APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer
title_sort apobec alteration contributes to tumor growth and immune escape in pan cancer
topic APOBEC
pan-cancer
genetic alterations
tumor microenvironment
survival
immunotherapy
url https://www.mdpi.com/2072-6694/14/12/2827
work_keys_str_mv AT honghongguo apobecalterationcontributestotumorgrowthandimmuneescapeinpancancer
AT lingzhu apobecalterationcontributestotumorgrowthandimmuneescapeinpancancer
AT luhuang apobecalterationcontributestotumorgrowthandimmuneescapeinpancancer
AT zhensun apobecalterationcontributestotumorgrowthandimmuneescapeinpancancer
AT huizhang apobecalterationcontributestotumorgrowthandimmuneescapeinpancancer
AT baotingnong apobecalterationcontributestotumorgrowthandimmuneescapeinpancancer
AT yuanyanxiong apobecalterationcontributestotumorgrowthandimmuneescapeinpancancer